Global Felodipine Sustained-Release Tablet Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

SKU ID : QYR-22146908 | Publishing Date : 24-Nov-2022 | No. of pages : 103

Detailed TOC of Global Felodipine Sustained-Release Tablet Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

1 Report Overview
    1.1 Research Scope
    1.2 Market Segment by Type
        1.2.1 Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
        1.2.2 2.5mg Per Tablet
        1.2.3 5mg Per Tablet
        1.2.4 Others
    1.3 Market Segment by Application
        1.3.1 Global Felodipine Sustained-Release Tablet Market Share by Application (2017 VS 2021 VS 2028)
        1.3.2 Treat High Blood Pressure
        1.3.3 Relieve Angina
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Market Perspective
    2.1 Global Felodipine Sustained-Release Tablet Market Size (2017-2028)
        2.1.1 Global Felodipine Sustained-Release Tablet Revenue (2017-2028)
        2.1.2 Global Felodipine Sustained-Release Tablet Sales (2017-2028)
    2.2 Global Felodipine Sustained-Release Tablet Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
        2.2.1 Global Felodipine Sustained-Release Tablet Sales by Regions (2017-2022)
        2.2.2 Global Felodipine Sustained-Release Tablet Revenue by Regions (2017-2022)
    2.3 Global Felodipine Sustained-Release Tablet Market Size Forecast by Region
        2.3.1 Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2023-2028)
        2.3.2 Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2023-2028)
    2.4 Global Top Felodipine Sustained-Release Tablet Regions (Countries) Ranking by Market Size
    2.5 Felodipine Sustained-Release Tablet  Market Dynamics
        2.5.1 Felodipine Sustained-Release Tablet Market Trends
        2.5.2 Felodipine Sustained-Release Tablet Market Drivers
        2.5.3 Felodipine Sustained-Release Tablet Market Challenges
        2.5.4 Felodipine Sustained-Release Tablet Market Restraints
3 Competitive Landscape by Manufacturers
    3.1 Global Top Felodipine Sustained-Release Tablet Manufacturers by Sales (2017-2022)
        3.1.1 Global Felodipine Sustained-Release Tablet Sales by Manufacturers (2017-2022)
        3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global 5 and 10 Largest Manufacturers by Felodipine Sustained-Release Tablet Sales in 2021
    3.2 Global Top Manufacturers Felodipine Sustained-Release Tablet by Revenue
        3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (2017-2022)
        3.2.2 Top Felodipine Sustained-Release Tablet Manufacturers Covered: Ranking by Revenue
        3.2.3 Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers (2017-2022)
        3.2.4 Global Felodipine Sustained-Release Tablet Market Concentration Ratio (CR5 and HHI)
    3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Felodipine Sustained-Release Tablet as of 2021)
    3.4 Global Felodipine Sustained-Release Tablet Average Selling Price (ASP) by Manufacturers
    3.5 Key Manufacturers Felodipine Sustained-Release Tablet Plants/Factories Distribution and Area Served
    3.6 Date of Key Manufacturers Enter into Felodipine Sustained-Release Tablet Market
    3.7 Key Manufacturers Felodipine Sustained-Release Tablet Product Offered
    3.8 Mergers & Acquisitions, Expansion Plans
4 Global Felodipine Sustained-Release Tablet Market Size by Type
    4.1 Global Felodipine Sustained-Release Tablet Historic Market Review by Type (2017-2022)
        4.1.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2022)
        4.1.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2022)
        4.1.3 Felodipine Sustained-Release Tablet Price by Type (2017-2022)
    4.2 Global Felodipine Sustained-Release Tablet Market Estimates and Forecasts by Type (2023-2028)
        4.2.1 Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2023-2028)
        4.2.2 Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2023-2028)
        4.2.3 Felodipine Sustained-Release Tablet Price Forecast by Type (2023-2028)
5 Global Felodipine Sustained-Release Tablet Market Size by Application
    5.1 Global Felodipine Sustained-Release Tablet Historic Market Review by Application (2017-2022)
        5.1.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2022)
        5.1.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2022)
        5.1.3 Felodipine Sustained-Release Tablet Price by Application (2017-2022)
    5.2 Global Felodipine Sustained-Release Tablet Market Estimates and Forecasts by Application (2023-2028)
        5.2.1 Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2023-2028)
        5.2.2 Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2023-2028)
        5.2.3 Felodipine Sustained-Release Tablet Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Felodipine Sustained-Release Tablet Sales Breakdown by Company
        6.1.1 North America Felodipine Sustained-Release Tablet Sales by Company (2017-2022)
        6.1.2 North America Felodipine Sustained-Release Tablet Revenue by Company (2017-2022)
    6.2 North America Felodipine Sustained-Release Tablet Market Size by Type
        6.2.1 North America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
        6.2.2 North America Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
    6.3 North America Felodipine Sustained-Release Tablet Market Size by Application
        6.3.1 North America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
        6.3.2 North America Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
    6.4 North America Felodipine Sustained-Release Tablet Market Size by Country
        6.4.1 North America Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
        6.4.2 North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Felodipine Sustained-Release Tablet Sales Breakdown by Company
        7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Company (2017-2022)
        7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Company (2017-2022)
    7.2 Europe Felodipine Sustained-Release Tablet Market Size by Type
        7.2.1 Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
        7.2.2 Europe Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
    7.3 Europe Felodipine Sustained-Release Tablet Market Size by Application
        7.3.1 Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
        7.3.2 Europe Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
    7.4 Europe Felodipine Sustained-Release Tablet Market Size by Country
        7.4.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
        7.4.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Felodipine Sustained-Release Tablet Sales Breakdown by Company
        8.1.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Company (2017-2022)
        8.1.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Company (2017-2022)
    8.2 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Type
        8.2.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
        8.2.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
    8.3 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Application
        8.3.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
        8.3.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
    8.4 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Region
        8.4.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Region
        8.4.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 India
        8.4.7 Australia
        8.4.8 China Taiwan
        8.4.9 Indonesia
        8.4.10 Thailand
        8.4.11 Malaysia
9 Latin America
    9.1 Latin America Felodipine Sustained-Release Tablet Sales Breakdown by Company
        9.1.1 Latin America Felodipine Sustained-Release Tablet Sales by Company (2017-2022)
        9.1.2 Latin America Felodipine Sustained-Release Tablet Revenue by Company (2017-2022)
    9.2 Latin America Felodipine Sustained-Release Tablet Market Size by Type
        9.2.1 Latin America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
        9.2.2 Latin America Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
    9.3 Latin America Felodipine Sustained-Release Tablet Market Size by Application
        9.3.1 Latin America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
        9.3.2 Latin America Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
    9.4 Latin America Felodipine Sustained-Release Tablet Market Size by Country
        9.4.1 Latin America Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
        9.4.2 Latin America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
        9.4.3 Mexico
        9.4.4 Brazil
        9.4.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales Breakdown by Company
        10.1.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Company (2017-2022)
        10.1.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Company (2017-2022)
    10.2 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Type
        10.2.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
        10.2.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
    10.3 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Application
        10.3.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
        10.3.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
    10.4 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country
        10.4.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2028)
        10.4.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Company Profiles
    11.1 Astrazeneca
        11.1.1 Astrazeneca Corporation Information
        11.1.2 Astrazeneca Overview
        11.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.1.4 Astrazeneca Felodipine Sustained-Release Tablet Products and Services
        11.1.5 Astrazeneca Felodipine Sustained-Release Tablet SWOT Analysis
        11.1.6 Astrazeneca Recent Developments
    11.2 NanJing Easeheal Phaemaecutical
        11.2.1 NanJing Easeheal Phaemaecutical Corporation Information
        11.2.2 NanJing Easeheal Phaemaecutical Overview
        11.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Products and Services
        11.2.5 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet SWOT Analysis
        11.2.6 NanJing Easeheal Phaemaecutical Recent Developments
    11.3 SHANXI KANGBO BIOLOGICAL PRODUCT
        11.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
        11.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Overview
        11.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Products and Services
        11.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet SWOT Analysis
        11.3.6 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
    11.4 Lifeon
        11.4.1 Lifeon Corporation Information
        11.4.2 Lifeon Overview
        11.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.4.4 Lifeon Felodipine Sustained-Release Tablet Products and Services
        11.4.5 Lifeon Felodipine Sustained-Release Tablet SWOT Analysis
        11.4.6 Lifeon Recent Developments
    11.5 Changzhou Siyao Pharmaceutical
        11.5.1 Changzhou Siyao Pharmaceutical Corporation Information
        11.5.2 Changzhou Siyao Pharmaceutical Overview
        11.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Products and Services
        11.5.5 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet SWOT Analysis
        11.5.6 Changzhou Siyao Pharmaceutical Recent Developments
    11.6 Mylan
        11.6.1 Mylan Corporation Information
        11.6.2 Mylan Overview
        11.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.6.4 Mylan Felodipine Sustained-Release Tablet Products and Services
        11.6.5 Mylan Felodipine Sustained-Release Tablet SWOT Analysis
        11.6.6 Mylan Recent Developments
    11.7 Sandoz
        11.7.1 Sandoz Corporation Information
        11.7.2 Sandoz Overview
        11.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
        11.7.4 Sandoz Felodipine Sustained-Release Tablet Products and Services
        11.7.5 Sandoz Felodipine Sustained-Release Tablet SWOT Analysis
        11.7.6 Sandoz Recent Developments
12 Value Chain and Sales Channels Analysis
    12.1 Felodipine Sustained-Release Tablet Value Chain Analysis
    12.2 Felodipine Sustained-Release Tablet Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Felodipine Sustained-Release Tablet Production Mode & Process
    12.4 Felodipine Sustained-Release Tablet Sales and Marketing
        12.4.1 Felodipine Sustained-Release Tablet Sales Channels
        12.4.2 Felodipine Sustained-Release Tablet Distributors
    12.5 Felodipine Sustained-Release Tablet Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Figures, Tables and Charts Available in Global Felodipine Sustained-Release Tablet Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Tables
    Table 1. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 2.5mg Per Tablet
    Table 3. Major Manufacturers of 5mg Per Tablet
    Table 4. Major Manufacturers of Others
    Table 5. Global Felodipine Sustained-Release Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Felodipine Sustained-Release Tablet Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 7. Global Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
    Table 8. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)
    Table 9. Global Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2017-2022)
    Table 11. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2023-2028) & (K Units)
    Table 12. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Region (2023-2028)
    Table 13. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2023-2028)
    Table 15. Top Felodipine Sustained-Release Tablet Regions (Countries) Ranking by Market Size (US$ Million) in 2021
    Table 16. Felodipine Sustained-Release Tablet Market Trends
    Table 17. Felodipine Sustained-Release Tablet Market Drivers
    Table 18. Felodipine Sustained-Release Tablet Market Challenges
    Table 19. Felodipine Sustained-Release Tablet Market Restraints
    Table 20. Global Felodipine Sustained-Release Tablet Sales by Manufacturers (2017-2022) & (K Units)
    Table 21. Global Felodipine Sustained-Release Tablet Sales Share by Manufacturers (2017-2022)
    Table 22. Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 23. Ranking of Global Top Felodipine Sustained-Release Tablet Manufacturers by Revenue (US$ Million) in 2021
    Table 24. Felodipine Sustained-Release Tablet Revenue Share by Manufacturers (2017-2022)
    Table 25. Global Felodipine Sustained-Release Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Felodipine Sustained-Release Tablet as of 2021)
    Table 27. Key Manufacturers Felodipine Sustained-Release Tablet Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
    Table 28. Key Manufacturers Felodipine Sustained-Release Tablet Plants/Factories Distribution
    Table 29. Key Manufacturers Felodipine Sustained-Release Tablet Area Served
    Table 30. Date of Key Manufacturers Enter into Felodipine Sustained-Release Tablet Market
    Table 31. Key Manufacturers Felodipine Sustained-Release Tablet Product Type
    Table 32. Mergers & Acquisitions, Expansion Plans
    Table 33. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2017-2022)
    Table 34. Global Felodipine Sustained-Release Tablet Sales Share by Type (2017-2022)
    Table 35. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) Market Share by Type (2017-2022)
    Table 36. Global Felodipine Sustained-Release Tablet Price (K Units) by Type (2017-2022)
    Table 37. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2023-2028)
    Table 38. Global Felodipine Sustained-Release Tablet Sales Share by Type (2023-2028)
    Table 39. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) Market Share by Type (2023-2028)
    Table 40. Global Felodipine Sustained-Release Tablet Revenue Share by Type (2023-2028)
    Table 41. Global Felodipine Sustained-Release Tablet Price (K Units) by Type (2023-2028)
    Table 42. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2017-2022)
    Table 43. Global Felodipine Sustained-Release Tablet Sales Share by Application (2017-2022)
    Table 44. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) Market Share by Application (2017-2022)
    Table 45. Global Felodipine Sustained-Release Tablet Price (K Units) by Application (2017-2022)
    Table 46. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2023-2028)
    Table 47. Global Felodipine Sustained-Release Tablet Sales Share by Application (2023-2028)
    Table 48. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) Market Share by Application (2023-2028)
    Table 49. Global Felodipine Sustained-Release Tablet Revenue Share by Application (2023-2028)
    Table 50. Global Felodipine Sustained-Release Tablet Price (K Units) by Application (2023-2028)
    Table 51. North America Felodipine Sustained-Release Tablet Sales by Company (2017-2022) & (K Units)
    Table 52. North America Felodipine Sustained-Release Tablet Sales Market Share by Company (2017-2022)
    Table 53. North America Felodipine Sustained-Release Tablet Revenue by Company (2017-2022) & (US$ Million)
    Table 54. North America Felodipine Sustained-Release Tablet Revenue Market Share by Company (2017-2022)
    Table 55. North America Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
    Table 56. North America Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
    Table 57. North America Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
    Table 58. North America Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
    Table 59. North America Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
    Table 60. North America Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
    Table 61. North America Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
    Table 62. North America Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
    Table 63. North America Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
    Table 64. North America Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
    Table 65. North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 66. North America Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
    Table 67. Europe Felodipine Sustained-Release Tablet Sales by Company (2017-2022) & (K Units)
    Table 68. Europe Felodipine Sustained-Release Tablet Sales Market Share by Company (2017-2022)
    Table 69. Europe Felodipine Sustained-Release Tablet Revenue by Company (2017-2022) & (US$ Million)
    Table 70. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Company (2017-2022)
    Table 71. Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
    Table 72. Europe Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
    Table 73. Europe Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Europe Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
    Table 76. Europe Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
    Table 77. Europe Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Europe Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Europe Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
    Table 80. Europe Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
    Table 81. Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 82. Europe Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
    Table 83. Asia Pacific Felodipine Sustained-Release Tablet Sales by Company (2017-2022) & (K Units)
    Table 84. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Company (2017-2022)
    Table 85. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Company (2017-2022) & (US$ Million)
    Table 86. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Company (2017-2022)
    Table 87. Asia Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
    Table 88. Asia Pacific Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
    Table 89. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
    Table 90. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
    Table 91. Asia Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
    Table 92. Asia Pacific Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
    Table 93. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
    Table 94. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
    Table 95. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2017-2022) & (K Units)
    Table 96. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2023-2028) & (K Units)
    Table 97. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2017-2022) & (US$ Million)
    Table 98. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2023-2028) & (US$ Million)
    Table 99. Latin America Felodipine Sustained-Release Tablet Sales by Company (2017-2022) & (K Units)
    Table 100. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Company (2017-2022)
    Table 101. Latin America Felodipine Sustained-Release Tablet Revenue by Company (2017-2022) & (US$ Million)
    Table 102. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Company (2017-2022)
    Table 103. Latin America Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
    Table 104. Latin America Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
    Table 105. Latin America Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
    Table 106. Latin America Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
    Table 107. Latin America Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
    Table 108. Latin America Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
    Table 109. Latin America Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
    Table 110. Latin America Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
    Table 111. Latin America Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
    Table 112. Latin America Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
    Table 113. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 114. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
    Table 115. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Company (2017-2022) & (K Units)
    Table 116. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Company (2017-2022)
    Table 117. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Company (2017-2022) & (US$ Million)
    Table 118. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Company (2017-2022)
    Table 119. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2022) & (K Units)
    Table 120. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Type (2023-2028) & (K Units)
    Table 121. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Type (2017-2022) & (US$ Million)
    Table 122. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Type (2023-2028) & (US$ Million)
    Table 123. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2022) & (K Units)
    Table 124. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Application (2023-2028) & (K Units)
    Table 125. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Application (2017-2022) & (US$ Million)
    Table 126. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Application (2023-2028) & (US$ Million)
    Table 127. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2017-2022) & (K Units)
    Table 128. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2023-2028) & (K Units)
    Table 129. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2022) & (US$ Million)
    Table 130. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2023-2028) & (US$ Million)
    Table 131. Astrazeneca Corporation Information
    Table 132. Astrazeneca Description and Overview
    Table 133. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Astrazeneca Felodipine Sustained-Release Tablet Product and Services
    Table 135. Astrazeneca Felodipine Sustained-Release Tablet SWOT Analysis
    Table 136. Astrazeneca Recent Developments
    Table 137. NanJing Easeheal Phaemaecutical Corporation Information
    Table 138. NanJing Easeheal Phaemaecutical Description and Overview
    Table 139. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 140. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
    Table 141. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet SWOT Analysis
    Table 142. NanJing Easeheal Phaemaecutical Recent Developments
    Table 143. SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
    Table 144. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Overview
    Table 145. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 146. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
    Table 147. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet SWOT Analysis
    Table 148. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
    Table 149. Lifeon Corporation Information
    Table 150. Lifeon Description and Overview
    Table 151. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 152. Lifeon Felodipine Sustained-Release Tablet Product and Services
    Table 153. Lifeon Felodipine Sustained-Release Tablet  SWOT Analysis
    Table 154. Lifeon Recent Developments
    Table 155. Changzhou Siyao Pharmaceutical Corporation Information
    Table 156. Changzhou Siyao Pharmaceutical Description and Overview
    Table 157. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
    Table 159. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet SWOT Analysis
    Table 160. Changzhou Siyao Pharmaceutical Recent Developments
    Table 161. Mylan Corporation Information
    Table 162. Mylan Description and Overview
    Table 163. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 164. Mylan Felodipine Sustained-Release Tablet Product and Services
    Table 165. Mylan Felodipine Sustained-Release Tablet SWOT Analysis
    Table 166. Mylan Recent Developments
    Table 167. Sandoz Corporation Information
    Table 168. Sandoz Description and Overview
    Table 169. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 170. Sandoz Felodipine Sustained-Release Tablet Product and Services
    Table 171. Sandoz Felodipine Sustained-Release Tablet SWOT Analysis
    Table 172. Sandoz Recent Developments
    Table 173. Key Raw Materials Lists
    Table 174. Raw Materials Key Suppliers Lists
    Table 175. Felodipine Sustained-Release Tablet Distributors List
    Table 176. Felodipine Sustained-Release Tablet Customers List
    Table 177. Research Programs/Design for This Report
    Table 178. Key Data Information from Secondary Sources
    Table 179. Key Data Information from Primary Sources
List of Figures
    Figure 1. Felodipine Sustained-Release Tablet Product Picture
    Figure 2. Global Felodipine Sustained-Release Tablet Sales Market Share by Type in 2021 & 2028
    Figure 3. 2.5mg Per Tablet Product Picture
    Figure 4. 5mg Per Tablet Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Felodipine Sustained-Release Tablet Sales Market Share by Application in 2021 & 2028
    Figure 7. Treat High Blood Pressure Use Case
    Figure 8. Relieve Angina Use Case
    Figure 9. Others Use Case
    Figure 10. Felodipine Sustained-Release Tablet Report Years Considered
    Figure 11. Global Felodipine Sustained-Release Tablet Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Felodipine Sustained-Release Tablet Market Size 2017-2028 (US$ Million)
    Figure 13. Global Felodipine Sustained-Release Tablet Sales (2017-2022) & (K Units)
    Figure 14. Global Felodipine Sustained-Release Tablet Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2017-2022)
    Figure 16. Global Felodipine Sustained-Release Tablet Sales Market Share by Region in 2021
    Figure 17. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region in 2017 VS 2021
    Figure 18. Global Felodipine Sustained-Release Tablet Sales Share by Manufacturers in 2021
    Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Felodipine Sustained-Release Tablet Sales in 2021
    Figure 20. Felodipine Sustained-Release Tablet Revenue Share by Manufacturers in 2021
    Figure 21. Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Felodipine Sustained-Release Tablet Revenue Share by Type (2017-2022)
    Figure 23. Global Felodipine Sustained-Release Tablet Revenue Growth Rate by Type in 2017 & 2021
    Figure 24. Global Felodipine Sustained-Release Tablet Revenue Share by Application (2017-2022)
    Figure 25. Global Felodipine Sustained-Release Tablet Revenue Growth Rate by Application in 2017 & 2021
    Figure 26. North America Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
    Figure 27. North America Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
    Figure 28. North America Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
    Figure 29. North America Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
    Figure 30. North America Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
    Figure 31. North America Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
    Figure 32. United States Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 33. Canada Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 34. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
    Figure 35. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
    Figure 36. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
    Figure 37. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
    Figure 38. Europe Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
    Figure 39. Europe Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
    Figure 40. Germany Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 41. France Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 42. U.K. Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 43. Italy Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 44. Russia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 45. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
    Figure 46. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
    Figure 47. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
    Figure 48. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
    Figure 49. Asia Pacific Felodipine Sustained-Release Tablet Sales Share by Region (2017-2028)
    Figure 50. Asia Pacific Felodipine Sustained-Release Tablet Revenue Share by Region (2017-2028)
    Figure 51. China Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 52. Japan Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 53. South Korea Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 54. India Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 55. Australia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 56. China Taiwan Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 57. Indonesia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 58. Thailand Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 59. Malaysia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 60. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
    Figure 61. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
    Figure 62. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
    Figure 63. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
    Figure 64. Latin America Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
    Figure 65. Latin America Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
    Figure 66. Mexico Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 67. Brazil Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 68. Argentina Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 69. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2017-2028)
    Figure 70. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Type (2017-2028)
    Figure 71. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2017-2028)
    Figure 72. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa Felodipine Sustained-Release Tablet Sales Share by Country (2017-2028)
    Figure 74. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Share by Country (2017-2028)
    Figure 75. Turkey Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 77. UAE Felodipine Sustained-Release Tablet Revenue (2017-2028) & (US$ Million)
    Figure 78. Felodipine Sustained-Release Tablet Value Chain
    Figure 79. Felodipine Sustained-Release Tablet Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed

Keyplayers in Global Felodipine Sustained-Release Tablet Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]